VEGFA and hepatocellular carcinoma: The demonstrated functions of miR-26a include greatly inhibiting the level at which HCC cells express vascular endothelial growth factor A and further suppressing, to some extent, HCC cell promotion of endothelial cell proliferation, metastasis, and capillary tube formation in vitro, which enhances HCC tumor angiogenesis in vivo22.